Abstract
Chronic total occlusion plaque modification (CTO-PM) is often used after unsuccessful CTO interventions to facilitate future attempts. We aimed to explore the safety and efficacy of both conventional (CB) and drug-coated balloons (DCB) for CTO-PM.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Journal of the Society for Cardiovascular Angiography & Interventions
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.